Home / Small molecules / Drug product / Parenteral
Parenteral Drug Product
Injectable development and sterile manufacture for all synthetic molecules, on one site network.
One platform for all synthetic molecules
The injectable formulation development and manufacturing platform is at the Wuxi City and Shanghai Waigaoqiao sites in China. It provides integrated R&D and manufacturing for all synthetic molecules, including small molecules, oligonucleotides, peptides, and complex chemical conjugates.
Formulation development and analytical teams complete 85,000+ characterization tests a year in injectable drug development, from preclinical through clinical trials to commercial launch.
Five production lines with fully enclosed isolation systems and automated filling run at more than 100 million units of annual capacity.
Drug types
- Small molecule
- Oligonucleotide
- Peptide
- Synthetic conjugate
- mRNA and DNA in lipid nanoparticle
Dose forms
- Solution
- Emulsion and suspension
- Lyophilized powder
- In-situ-forming hydrogels
- Advanced formulations, including liposomes, lipid nanoparticles, and nanoparticles
Filling formats and sterilization
- Filling formats: vials, prefilled syringes, cartridges, and LDPE ampoules
- Sterilization: sterile filtration, heat-moist sterilization, irradiation